Syndrome News and Research

RSS

The features of the newly emerging SARS-CoV-2 Omicron BA.2.75 subvariant

Researchers evaluated all the features, especially the antigenic properties and transmission potential of SARS-CoV-2 Omicron sub-variant BA.2.75.

10 Aug 2022

Scientists present highly accurate novel framework for SARS-CoV-2 genomic surveillance

Researchers presented a novel framework for SARS-CoV-2 genomic surveillance based on case studies from New York, the United States, and the United Kingdom in a new study.

10 Aug 2022

A direct lineage-typing RT-PCR assay reveals insights into the transition from Omicron BA.1 to BA.2 dominance in Sweden

Researchers monitored the remarkably rapid Omicron BA.1 to BA.2 sublineage dominance transition in the Swedish population in early 2022 on a day-to-day basis using a customized lineage-typing RT-PCR assay.

10 Aug 2022

Researchers explore SARS-CoV-2 entry route and downstream cellular and viral processes

In a new study, researchers assessed the impact of the SARS-CoV-2 entry route on downstream cellular and viral processes.

10 Aug 2022

Coronavirus biology: viral RNA synthesis, origin, and vaccines

Researchers analyzed the characteristics of coronaviruses and novel CoV vaccine candidates.

10 Aug 2022

Study evaluates two immunization schedules for the inactivated SARS-CoV-2 vaccine Coronavac

Researchers conducted phase 3 evaluations of the immunogenicity of the two immunization timeframes of the CoronaVac COVID-19 vaccine among Chilean adults.

10 Aug 2022

Study finds climate hazards can aggravate over half of known human infectious diseases

A recent article posted to the journal Nature Climate Change demonstrated that climate change could aggravate about 50% of recognized human pathogenic illnesses.

10 Aug 2022

A novel 3D-printed lab-on-a-chip device concurrently detects SARS-CoV-2 nucleic acid and anti-SARS-CoV-2 antibodies in saliva

Researchers described the development and applications of a 3D-printed lab-on-a-chip device that quickly detected the presence of SARS-CoV-2 in patient's saliva.

10 Aug 2022

A broad sarbecovirus-neutralizing antibody cocktail

Researchers present a rational approach for identifying SARS-CoV-2 receptor-binding domain-targeted broad neutralizing antibody cocktails.

9 Aug 2022

Antibody evasion of Omicron BA.2.75 is less pronounced than BA.4/5

Researchers assess the sensitivity of the SARS-CoV-2 Omicron BA.2.75 sublineage to neutralization.

9 Aug 2022

Neuronal cilia are important for dopamine receptor 1 signaling, study shows

A historically overlooked rod-like projection present on nearly every cell type in the human body may finally be getting its scientific due: A new study has found that these appendages, called cilia, on neurons in the brain have a key role in ensuring a specific dopamine receptor's signals are properly received.

9 Aug 2022

Gen Zs with Down syndrome have high aspirations and a great zest for life, study reveals

Young adults living with Down syndrome have high aspirations and a great zest for life according to an Australian first study by researchers from The University of Queensland.

9 Aug 2022

Icelandic study suggests SARS-CoV-2 Omicron reinfection more common than previously thought

Researchers estimate the proportion of Icelandic residents reinfected with the SARS-CoV-2 Omicron variant.

9 Aug 2022

Lower risk of MIS-C during Omicron wave

Researchers estimate the risk of multisystem inflammatory syndrome in children (MIS-C) in Denmark.

9 Aug 2022

B-cell responses to COVID mRNA vaccine are enhanced by a 16-week interval between doses

Researchers assess the impact of extending the interval between primary and booster COVID-19 vaccine doses.

9 Aug 2022

SARS-CoV-2 infection in mothers does not have a significant teratogenic effect

Scientists determine that infection with SARS-CoV-2 during the first trimester of pregnancy does not increase the risk of any specific congenital malformations.

9 Aug 2022

Double mRNA COVID-19 vaccination found to increase SARS-CoV-2 variant recognition

Researchers evaluated the impact of double BNT162b2 messenger ribonucleic acid (mRNA) vaccination in recognition of SARS-CoV-2 variants of concern.

9 Aug 2022

Almost 90% of subjects who experience COVID-19-linked taste or smell dysfunction fully recover after two years

Researchers explored the recovery rate and prevalence of the COVID-19-associated taste and smell impairments after two years across patients with mild symptoms.

9 Aug 2022

How does COVID-19 rebound after Paxlovid treatment differ between the BA.5 and BA.2.12.1 subvariants?

Scientists analyzed the differences between SARS-CoV-2 rebound associated with the Omicron BA.2.12.1 and BA.5 sublineages post-Paxlovid therapy in the United States.

9 Aug 2022

The neutralizing activity of a panel of 482 human monoclonal antibodies against Omicron BA.4 and BA.5

Researchers demonstrated differential utilization of the B cell germlines and SARS-CoV-2 spike protein epitopes by cross-neutralizing antibodies in infected, vaccinated and individuals with hybrid immunity.

9 Aug 2022

Syndrome News and Research

The features of the newly emerging SARS-CoV-2 Omicron BA.2.75 subvariant

Scientists present highly accurate novel framework for SARS-CoV-2 genomic surveillance

A direct lineage-typing RT-PCR assay reveals insights into the transition from Omicron BA.1 to BA.2 dominance in Sweden

Researchers explore SARS-CoV-2 entry route and downstream cellular and viral processes

Coronavirus biology: viral RNA synthesis, origin, and vaccines

Study evaluates two immunization schedules for the inactivated SARS-CoV-2 vaccine Coronavac

Study finds climate hazards can aggravate over half of known human infectious diseases

A novel 3D-printed lab-on-a-chip device concurrently detects SARS-CoV-2 nucleic acid and anti-SARS-CoV-2 antibodies in saliva

A broad sarbecovirus-neutralizing antibody cocktail

Antibody evasion of Omicron BA.2.75 is less pronounced than BA.4/5

Neuronal cilia are important for dopamine receptor 1 signaling, study shows

Gen Zs with Down syndrome have high aspirations and a great zest for life, study reveals

Icelandic study suggests SARS-CoV-2 Omicron reinfection more common than previously thought

Lower risk of MIS-C during Omicron wave

B-cell responses to COVID mRNA vaccine are enhanced by a 16-week interval between doses

SARS-CoV-2 infection in mothers does not have a significant teratogenic effect

Double mRNA COVID-19 vaccination found to increase SARS-CoV-2 variant recognition

Almost 90% of subjects who experience COVID-19-linked taste or smell dysfunction fully recover after two years

How does COVID-19 rebound after Paxlovid treatment differ between the BA.5 and BA.2.12.1 subvariants?

The neutralizing activity of a panel of 482 human monoclonal antibodies against Omicron BA.4 and BA.5

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News